Probably Genetic provides rare disease patients with free genetic testing, helping patients access diagnoses, clinical trials, and treatments earlier in their medical journeys. We identify undiagnosed patients online using our proprietary machine learning platform and test them for free with our at-home genetic testing service. Backed by Y Combinator and Khosla Ventures, Probably Genetic works with publicly traded biotech companies and patient foundations onn a mission to help the 200 million rare disease patients worldwide get tested. Our team consists of PhDs and Rhodes Scholars from Oxford, Cambridge, and Yale, specializing in genetics and artificial intelligence. Learn more at https://www.probablygenetic.com/sponsored-programs.